| Tomillero A, Moral MA
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 May; 31(4):263-98.
Abstract | Full Citation |
| Montella L, Addeo R, Guarrasi R, et al.
Once-per-cycle pegfilgrastim in breast cancer patients treated with docetaxel/epidoxorubicin/cyclophosphamide. [JOURNAL ARTICLE]
Eur J Cancer Care (Engl) 2009 Jun 22.
Abstract | Full Citation | Find Related Articles |
| Lyman GH, Lalla A, Barron RL, et al.
Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the united states. [Journal Article]
Clin Ther 2009 May; 31(5):1092-104.
Abstract | Full Citation | Find Related Articles |
| Weycker D, Malin J, Kim J, et al.
Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: A retrospective cohort study. [Journal Article]
Clin Ther 2009 May; 31(5):1069-81.
Abstract | Full Citation | Find Related Articles |
| Tomillero A, Moral MA
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 Apr; 31(3):183-227.
Abstract | Full Citation |
| Garg P, Rana F, Gupta R, et al.
Predictors of Toxicity and Toxicity Profile of Adjuvant Chemotherapy in Elderly Breast Cancer Patients. [JOURNAL ARTICLE]
Breast J 2009 Jun 9.
Abstract | Full Citation | Find Related Articles |
| Quirion E
Filgrastim and pegfilgrastim use in patients with neutropeni. [Journal Article]
Clin J Oncol Nurs 2009 Jun; 13(3):324-8.
Abstract | Full Citation |
| Borinstein SC, Pollard J, Winter L, et al.
Pegfilgrastim for prevention of chemotherapy-associated neutropenia in pediatric patients with solid tumors. [JOURNAL ARTICLE]
Pediatr Blood Cancer 2009 May 29.
Abstract | Full Citation | Find Related Articles |
| Tomillero A, Moral MA
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 Mar; 31(2):107-46.
Abstract | Full Citation |
| Tan Sean P, Chouaid C, Hettler D, et al.
Economic implications of using pegfilgrastim rather than conventional G-CSF to prevent neutropenia during small-cell lung cancer chemotherapy. [JOURNAL ARTICLE]
Curr Med Res Opin 2009 May 6.
Abstract | Full Citation |
  |
